Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Naloxon

Opt-out versus opt-in: should take-home naloxone be required as safe clinical practice?

Opt-out versus opt-in: should take-home naloxone be required as safe clinical practice?

John Strang, Lisbon Addictions 2017, Second European Conference on Addictive Behaviours and Dependencies, Lissabon, 24.-26.10.2017

http://www.emcdda.europa.eu/system/files/attachments/6728/12H45_4_John Strang.pptx